InvestorsHub Logo
icon url

georgebailey

09/21/23 6:43 AM

#633124 RE: DocLee #633117

DocLee what happened in Germany? They required production in Germany and LP said no. What does the CCCP require?
It’s this requirement that fascilitates IP issues.
icon url

abeta

09/21/23 8:28 AM

#633133 RE: DocLee #633117

and what's the betting that the Chinese produce their own version of DCVax-L (and all the rest) which is either identical (or as nearly so as to make no difference) to DCVax-L but for which they have no licence nor pay royalties not have any intention of doing either. Closely followed by the Indian pharmaceutical industry who might be persuaded to at least acknowledge the origin of their version and to call it by another name.



the complicated answer is they didn't with either (a) Temozolomide (tmz) nor (b) Novacure (TTF)

The narrative I have been posting is all tumors goto the UK ....
not that someone else is producing DCVax

the uncomplicated answer is


the really really good new is - we are gonna find out ......
icon url

CaptainObvious

09/21/23 8:32 AM

#633134 RE: DocLee #633117

China has ascended mostly through thievery, but are now competing with us mostly on their own.
Bullish
Bullish
icon url

biosectinvestor

09/21/23 10:13 AM

#633186 RE: DocLee #633117

NWBO doesn’t need China at the current time. China is cratering, their national healthcare is abysmal, and it’s just not a place anyone wants to go to these days.

Japan, South Korea, Taiwan, etc. these are the places to go.